Distinguished Advisory Group
We are supported by an extensive group of trusted advisors with expertise in all areas of pharmaceutical sciences, including regulatory affairs, drug delivery, pharmacology, skin diseases, nanotechnology, prodrugs, digital R&D, and gene therapy.
Ronald van Vollenhofen, MD/PhD – RA KOL, Chair of Rheumatology at University of Amsterdam, The Netherlands
Ian Wilding, PhD – FDA consultant in biopharmaceutics, world-renowned oral drug delivery expert, entrepreneur and board member in the United Kingdom
Daan Crommelin, PhD – prof. emeritus U. Utrecht in The Netherlands, nanotechnology and protein pharmaceuticals, complex drug product regulatory CMC expert, mRNA product advisor to the WHO
Daníel Ó. Frímannsson, PhD – gene therapy and systems biology expert, plasmid, guide oligo and mRNA production
Dan Deaver, PhD – 40+ years academic and industry expertise, in vivo pharmacology, toxicology consultant, including prodrugs, complex injectables
Jóhann E. Guðjónsson, MD, PhD – Arthur C Curtis Prof. of Skin Molecular Immunology, Prof. Dermatology; U. Michigan
Iain McFadyen, PhD – CD(S)O with a proven track record of building, leading, and developing impactful computational sciences and digital systems teams
